Menu Close
The Conversation

Julian Clark

1

Article

0

Comments
Business Development Manager, Walter and Eliza Hall Institute

Dr Julian Clark is currently Head of Business Development at the Walter and Eliza Hall Institute in Melbourne, responsible for IP management, technology transfer, commercial collaborations,and opportunity development. Julian has more than 30 years of international and cross-cultural business experience in growing and leading technology, research and healthcare enterprises, large and small. Julian also operates his own consulting business, Julian Clark Consulting Pty Ltd., and has had senior executive positions in Sweden, Great Britain, Japan, North America, India and Australia, including being CEO of Pharmacia LKB Biotech AB (Uppsala, Sweden), Chairman/Managing Director of Biochrom Limited (Cambridge, UK), and Chief Operating Officer of Faulding Pharma Limited (Adelaide, Australia).

Julian is a Fellow of the Australian Academy of Technological Sciences and Engineering, and a Member of the Australian Institute of Company Directors. Recently, he was the founding CEO of the Cancer Therapeutics CRC, a Director of Alchemia Limited and Genera Biosystems Limited. He has a PhD from the University of Glasgow and an Honorary Doctorate from the University of South Australia. Currently, Julian is also a Director of Cancer Trials Australia, BioGrid Australia, and BACE Therapeutics.

Experience

  • 2003–present
    Head of Business Development, Walter and Eliza Hall Institute of Medical Research
  • 1999–present
    Director, Julian Clark Consulting Pty. Ltd.

Education

  • 1998 
    University of South Australia, Doctor of the University
  • 1976 
    University of Glasgow, PhD
  • 1972 
    Flinders University of South Australia, Bachelor of Science (Honours)

Publications

  • 2011
    Do patents and intellectual property protection hinder biomedical research? A practical perspective, Australian Economic Review
  • 2007
    Why should we coopetite?, Fast Thinking
  • 2002
    Cooperate for long term industry gain, Natural Health Review
  • 2002
    Regulation from a consumer and supplier perspective, Natural Health Review

Research Areas

  • Medical Biotechnology Diagnostics (Incl. Biosensors) (100402)
  • Clinical Pharmacology And Therapeutics (111502)
  • Medical Biotechnology (1004)
  • Industrial Biotechnology (1003)
  • Business And Management (1503)
  • Marketing Management (Incl. Strategy And Customer Relations) (150503)

Honours

Fellow of the Australian Academy of Technological Sciences and Engineering